Research graph
References from Extracardiac imaging biomarkers of cardiovascular health: a comprehensive review. Local targets link to admitted publications; unresolved targets remain external evidence.
Opportunistic screening: radiology scientific expert panel
10.1148/radiol.222044 · 2023 · External reference
Osteoporosis and its association with cardiovascular disease, respiratory disease, and cancer: findings from the UK Biobank Prospective Cohort Study
10.1016/j.mayocp.2021.07.019 · 2022 · External reference
The associations between bone mineral density and long-term risks of cardiovascular disease, cancer, and all-cause mortality
10.3389/fendo.2022.938399 · 2022 · External reference
The link between osteoporosis and cardiovascular disease
2008 · External reference
Vascular calcification and bone disease: the calcification paradox
10.1016/j.molmed.2009.07.001 · 2009 · External reference
The bone-vascular axis: the link between osteoporosis and vascular calcification
10.1007/s11010-025-05210-5 · 2025 · External reference
Osteoporosis and cardiovascular disease: a review
10.1007/s11033-022-08088-4 · 2023 · External reference
The essential role of dual-energy X-ray absorptiometry in the prediction of subclinical cardiovascular disease
10.3389/fcvm.2024.1377299 · 2024 · External reference
Value-added opportunistic CT: insights into osteoporosis and sarcopenia
10.2214/ajr.20.22874 · 2020 · External reference
Osteoporosis and ischemic cardiovascular disease
10.1016/j.jbspin.2016.09.022 · 2017 · External reference
Calcaneal quantitative ultrasound is associated with all-cause and cardiovascular disease mortality independent of hip bone mineral density
10.1007/s00198-022-06317-x · 2022 · External reference
Bone health, cardiovascular disease, and imaging outcomes in UK Biobank: a causal analysis
10.1093/jbmrpl/ziae058 · 2024 · External reference
The venular side of cerebral amyloid angiopathy: proof of concept of a neglected issue
10.3390/biomedicines11102663 · 2023 · External reference
MarkVCID2 consortium for clinical validation of biomarkers of cerebral small vessel disease: validation framework and baseline characteristics
10.1002/ana.78040 · 2025 · External reference
Exploration of heterogeneity in risk factors associated with imaging subtypes of white matter hyperintensities on fluid-attenuated inversion recovery magnetic resonance imaging
10.3389/fneur.2025.1647065 · 2025 · External reference
Correlation between cerebral small vessel disease and late-life depression: insights from neuroimaging studies
10.1016/j.brainres.2025.150001 · 2025 · External reference
Mechanistic insights and translational therapeutics of neurovascular unit dysregulation in vascular cognitive impairment
10.31083/jin40091 · 2025 · External reference
Cardiovascular risk factors are associated with cerebrovascular reactivity in young adults
10.1016/j.ijcard.2025.133021 · 2025 · External reference
Linking peripheral atherosclerosis to blood-brain barrier disruption: elucidating its role as a manifestation of cerebral small vessel disease in vascular cognitive impairment
10.1007/s11357-024-01194-0 · 2024 · External reference
High-sensitivity cardiac troponin T and cognitive function over 12 months after stroke-results of the DEMDAS study
10.1161/jaha.123.033439 · 2024 · External reference
White matter hyperintensity and cardiovascular disease outcomes in the SPRINT MIND trial
10.1016/j.jstrokecerebrovasdis.2021.105764 · 2021 · External reference
Neuroimaging and genetic markers of cerebral small vessel disease and cognitive outcomes: a systematic review and meta-analysis (NEUROGEN-SVD study)
10.3390/diagnostics15202585 · 2025 · External reference
Differences in cerebral small vessel disease magnetic resonance imaging depending on cardiovascular risk factors: a retrospective cross-sectional study
10.3390/brainsci15080804 · 2025 · External reference
Synthetic MRI for stroke: a qualitative and quantitative pilot study
10.1038/s41598-022-15204-8 · 2022 · External reference
Cerebrovascular compromise and cognitive decline driven by chronic heart failure
10.3389/fneur.2025.1644634 · 2025 · External reference
Cerebral small-vessel disease markers on magnetic resonance imaging as predictors of recurrent vascular events and death in ischemic stroke: a systematic review and meta-analysis
10.1161/jaha.124.040082 · 2025 · External reference
Mediation analysis of brain magnetic resonance imaging variables with all-cause and cardiovascular disease-specific mortalities in persons with type 2 diabetes
10.1007/s00592-024-02387-x · 2025 · External reference
Carotid intima-media thickness and silent brain infarctions in a biracial cohort: the atherosclerosis risk in communities (ARIC) study
10.1093/ajh/hpy022 · 2018 · External reference
Neuroimaging standards for research into small vessel disease-advances since 2013
10.1016/s1474-4422(23)00131-x · 2023 · External reference
Covert cerebrovascular changes in people with heart disease: a systematic review and meta-analysis
10.1212/wnl.0000000000209204 · 2024 · External reference
Silent brain infarctions in patients with acute cardioembolic stroke
10.1016/j.jdmv.2024.02.003 · 2024 · External reference
Visceral adipose tissue is an independent predictor and mediator of the progression of coronary calcification: a prospective sub-analysis of the GEA study
10.1186/s12933-023-01807-6 · 2023 · External reference
Automated CT biomarkers for opportunistic prediction of future cardiovascular events and mortality in an asymptomatic screening population: a retrospective cohort study
10.1016/s2589-7500 · 2020 · External reference
Opportunistic screening at abdominal CT: use of automated body composition biomarkers for added cardiometabolic value
10.1148/rg.2021200056 · 2021 · External reference
CT-derived body fat distribution and incident cardiovascular disease: the multi-ethnic study of atherosclerosis
10.1210/jc.2017-01113 · 2017 · External reference
Fully automated CT-based adiposity assessment: comparison of the L1 and L3 vertebral levels for opportunistic prediction
10.1007/s00261-022-03728-6 · 2023 · External reference
Quantitative assessment of pancreatic fat by quantitative CT in type 2 diabetes mellitus
10.2147/ijgm.s383783 · 2022 · External reference
Pancreatic steatosis and metabolic pancreatic disease: a new entity?
10.1007/s11739-023-03364-y · 2023 · External reference
Perirenal fat thickness contributes to the estimated 10-year risk of cardiovascular disease and atherosclerotic cardiovascular disease in type 2 diabetes mellitus
10.3389/fendo.2024.1434333 · 2024 · External reference
Artificial intelligence prediction of cardiovascular events using opportunistic epicardial adipose tissue assessments from computed tomography calcium score
10.1016/j.jacadv.2024.101188 · 2024 · External reference
Metabolic syndrome screening using visceral adipose tissue (VAT) from opportunistic MRI locations in a multi-ethnic population
10.1016/j.orcp.2021.03.007 · 2021 · External reference
Stand-alone MRI tool for semiautomatic volumetry of abdominal adipose compartments in patients with obesity
10.1038/s41598-025-87578-4 · 2025 · External reference
MRI-Measured pancreatic fat correlates with increased arterial stiffness in patients who are overweight and obese
10.2147/dmso.s456172 · 2024 · External reference
Epicardial fat tissue in patients with diabetes mellitus: a systematic review and meta-analysis
10.1186/s12933-019-0807-3 · 2019 · External reference
Abdominal fat sonographic measurement compared to anthropometric indices for predicting the presence of coronary artery disease
10.7863/ultra.32.11.1957 · 2013 · External reference
Ultrasound-based assessment of preperitoneal fat as a surrogate marker of cardiovascular risk: comparative study between people living with HIV and controls
10.1089/aid.2021.0141 · 2022 · External reference
Ultrasound measurement of perirenal adipose tissue indicates cardiovascular disease, but standardisation is needed: a systematic review
10.1002/ajum.12407 · 2025 · External reference
Adiposity, fat depots and the prediction of stroke
10.5603/cj.a2021.0134 · 2023 · External reference
The relationship between DXA-based and anthropometric measures of visceral fat and morbidity in women
10.1186/1471-2261-13-25 · 2013 · External reference
DXA measured visceral adipose tissue, total fat, anthropometric indices and its association with cardiometabolic risk factors in mother-daughter pairs from India
10.1016/j.jocd.2020.06.001 · 2021 · External reference
Visceral adipose tissue measured by DXA predicts metabolic syndrome in low-income community-dwelling elderly: insights from the São Paulo Aging & Health (SPAH) study
10.1016/j.bone.2024.117308 · 2025 · External reference
Cardiovascular disease and its relationship with chronic kidney disease
2014 · External reference
Diagnosis of cardiovascular disease in patients with chronic kidney disease
10.1038/s41581-023-00747-4 · 2023 · External reference
Left ventricular hypertrophy and endothelial dysfunction in chronic kidney disease
10.1093/ehjci/jet120 · 2014 · External reference
Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease
10.1038/s41581-022-00616-6 · 2022 · External reference
Indoxyl sulfate, a uremic endotheliotoxin
10.3390/toxins12040229 · 2020 · External reference
Chronic kidney disease and pulse wave velocity: a narrative review
10.1155/2019/9189362 · 2019 · External reference
Hypertension, left ventricular hypertrophy and chronic kidney disease
10.1007/s10741-010-9197-z · 2011 · External reference
Comparison of value of 640-slice CT kidney scan and kidney ultrasound in the diagnosis of chronic kidney disease
10.1080/02648725.2023.2197379 · 2024 · External reference
Functional magnetic resonance imaging for staging chronic kidney disease: a systematic review and meta-analysis
10.1007/s11255-024-04055-z · 2024 · External reference
Relation between kidney length and cardiovascular and renal risk in high-risk patients
10.2215/cjn.08990816 · 2017 · External reference
Targeting vascular calcification in chronic kidney disease
10.1016/j.jacbts.2020.02.002 · 2020 · External reference
Understanding vascular calcification in chronic kidney disease: pathogenesis and therapeutic implications
10.3390/ijms252313096 · 2024 · External reference
Renal artery stenosis and cardiovascular risk
10.1111/j.1524-6175.2007.06113.x · 2007 · External reference
Renal resistive index and long-term outcome in patients with coronary artery disease
10.1186/s12872-020-01607-w · 2020 · External reference
A clinical association between an increasing renal resistive index and the atherosclerotic burden in patients with a preserved renal function
10.2169/internalmedicine.3232-19 · 2020 · External reference
Evaluation of interstitial fibrosis in chronic kidney disease by multiparametric functional MRI and histopathologic analysis
10.1007/s00330-022-09329-7 · 2023 · External reference
Noninvasive diagnosis of interstitial fibrosis in chronic kidney disease: a systematic review and meta-analysis
10.1080/0886022x.2024.2367021 · 2024 · External reference
4D flow MRI for the assessment of renal transplant dysfunction: initial results
10.1007/s00330-020-07208-7 · 2021 · External reference
AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease
10.1097/hep.0000000000000323 · 2023 · External reference
Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review
10.7570/jomes23052 · 2023 · External reference
NAFLD and cardiovascular diseases: a clinical review
10.1007/s00392-020-01709-7 · 2021 · External reference
Association of hepatic steatosis with major adverse cardiovascular events, independent of coronary artery disease
10.1016/j.cgh.2020.07.030 · 2021 · External reference
Pathophysiological mechanisms of cardiovascular disorders in non-alcoholic fatty liver disease
10.22037/ghfbb.v15i3.2549 · 2022 · External reference
Endothelial cell dysfunction and nonalcoholic fatty liver disease (NAFLD): a concise review
10.3390/cells11162511 · 2022 · External reference
Quantification of liver fat content with CT and MRI: state of the art
10.1148/radiol.2021204288 · 2021 · External reference
Liver fat imaging-a clinical overview of ultrasound, CT, and MR imaging
10.1259/bjr.20170959 · 2018 · External reference
Multimodality imaging in metabolic syndrome: state-of-the-art review
10.1148/rg.230083 · 2024 · External reference
Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis
10.1002/hep.29302 · 2017 · External reference
Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease
10.1016/j.jhep.2013.09.002 · 2014 · External reference
Correlations between MRI biomarkers PDFF and cT1 with histopathological features of non-alcoholic steatohepatitis
10.3389/fendo.2020.575843 · 2020 · External reference
High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial
10.1148/radiol.14140933 · 2015 · External reference
Potential drawbacks of noninvasive diagnostic methods for nonalcoholic fatty liver disease
10.3122/jabfm.2023.230005r2 · 2024 · External reference
US quantification of liver fat: past, present, and future
10.1148/rg.220178 · 2023 · External reference
Discordance diagnosis between B-mode ultrasonography and MRI proton density fat fraction for fatty liver
10.1038/s41598-023-42422-5 · 2023 · External reference
US attenuation for liver fat quantification: an AIUM-RSNA QIBA pulse-echo quantitative ultrasound initiative
10.1148/radiol.210736 · 2022 · External reference
Quantitative evaluation of hepatic steatosis using advanced imaging techniques: focusing on new quantitative ultrasound techniques
10.3348/kjr.2021.0112 · 2022 · External reference
Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease
10.1161/01.cir.0000056767.69054.b3 · 2003 · External reference
COPD as an endothelial disorder: endothelial injury linking lesions in the lungs and other organs? (2017 Grover conference series)
10.1177/2045894018758528 · 2018 · External reference
COPD: pulmonary vascular volume associated with cardiac structure and function
10.1007/s10554-023-03027-1 · 2024 · External reference
Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation
10.1378/chest.09-2810 · 2010 · External reference
The association between lung hyperinflation and coronary artery disease in smokers
10.1016/j.chest.2021.04.066 · 2021 · External reference
Combining pulmonary and cardiac computed tomography biomarkers for disease-specific risk modelling in lung cancer screening
10.1183/13993003.03386-2020 · 2021 · External reference
Significant incidental findings in the national lung screening trial
10.1001/jamainternmed.2023.1116 · 2023 · External reference
Emphysema at baseline low-dose CT lung cancer screening predicts death from chronic obstructive pulmonary disease and cardiovascular disease up to 25 years later
10.1148/radiol.250949 · 2025 · External reference
Chronic pancreatitis: Pain and computed tomography/magnetic resonance imaging findings
10.4329/wjr.v16.i3.40 · 2024 · External reference
Chronic pancreatitis and the heart disease: still terra incognita?
10.3748/wjg.v25.i44.6561 · 2019 · External reference
Management of pancreatic exocrine insufficiency
10.1097/mog.0000000000000562 · 2019 · External reference
Pancreatic exocrine insufficiency and cardiovascular risk in patients with chronic pancreatitis: a prospective, longitudinal cohort study
10.1111/jgh.14460 · 2019 · External reference
Association of pancreas volume with adverse clinical outcomes
10.1161/jaha.125.042348 · 2025 · External reference
Association of muscle wasting with mortality risk among adults: a systematic review and meta-analysis of prospective studies
10.1002/jcsm.13263 · 2023 · External reference
Association of low muscle mass and obesity with increased all-cause and cardiovascular disease mortality in US adults
10.1002/jcsm.13397 · 2024 · External reference
Cachexia, muscle wasting, and frailty in cardiovascular disease
10.1002/ejhf.2011 · 2020 · External reference
TAVI success is more than just the valve: CT-derived sarcopenia as a major determinant of long-term survival
10.1002/jcsm.70012 · 2025 · External reference
Relationship between sarcopenia and cardiovascular diseases in the elderly: an overview
10.3389/fcvm.2021.743710 · 2021 · External reference
Skeletal muscle quality as assessed by CT-derived skeletal muscle density is associated with 6-month mortality in mechanically ventilated critically ill patients
10.1186/s13054-016-1563-3 · 2016 · External reference
Computed tomography measured epicardial adipose tissue and psoas muscle attenuation: new biomarkers to predict major adverse cardiac events and mortality in patients with heart disease and critically ill patients. Part II: Psoas muscle area and density
10.5114/ait.2023.132460 · 2023 · External reference
The role of imaging biomarkers in the assessment of sarcopenia
10.3390/diagnostics10080534 · 2020 · External reference
Prognostic impact of muscle ultrasound-guided diagnosis of sarcopenia in older adults with severe aortic stenosis
10.1007/s41999-024-01042-6 · 2024 · External reference
Carotid intima-media thickness progression as surrogate marker for cardiovascular risk: meta-analysis of 119 clinical trials involving 100,667 patients
10.1161/circulationaha.120.046361 · 2020 · External reference
Age-related trends in the predictive value of carotid intima-media thickness for cardiovascular death: a prospective population-based cohort study
10.1161/jaha.123.029656 · 2023 · External reference
Does nonenhanced CT-based quantification of abdominal aortic calcification outperform the Framingham risk score in predicting cardiovascular events in asymptomatic adults?
10.1148/radiol.2018180562 · 2019 · External reference
Aortic arch calcification detectable on chest X-ray is a strong independent predictor of cardiovascular events beyond traditional risk factors
10.1016/j.atherosclerosis.2009.11.012 · 2010 · External reference
Breast arterial calcification is associated with the progression of coronary atherosclerosis in asymptomatic women: a preliminary retrospective cohort study
10.1038/s41598-020-59606-y · 2020 · External reference
Breast arterial calcification: expanding the reach of cardiovascular prevention
10.1161/circulationaha.116.025277 · 2017 · External reference
Automated breast arterial calcification score is associated with cardiovascular outcomes and mortality
10.1016/j.jacadv.2024.101283 · 2024 · External reference
Mammographic detection of breast arterial calcification as an independent predictor of coronary atherosclerotic disease in a single ethnic cohort of African American women
10.1016/j.atherosclerosis.2015.07.004 · 2015 · External reference
Breast arterial calcifications as a biomarker of cardiovascular risk: radiologists’ awareness, reporting, and action. A survey among the EUSOBI members
10.1007/s00330-020-07136-6 · 2021 · External reference
Breast arterial calcifications on mammography: a new marker of cardiovascular risk in asymptomatic middle age women?
10.1007/s00330-022-08571-3 · 2022 · External reference
Artificial intelligence-based software for breast arterial calcification detection on mammograms
10.1093/jbi/wbae064 · 2025 · External reference
Opportunistic osteoporosis screening at routine abdominal and thoracic CT: normative L1 trabecular attenuation values in more than 20,000 adults
10.1148/radiol.2019181648 · 2019 · External reference
